Heart Surgery Still Beats Stents Despite New Study Findings

A critical look at the endpoint adjustments (changes in how researchers measured outcomes) in the FAME 3 trial and their impact on coronary artery disease treatment guidelines.

Topline:

Despite changes to the outcomes measured that altered conclusions in recent reports, the 5-year results of the FAME 3 trial confirm coronary artery bypass graft surgery (CABG) remains superior to percutaneous coronary intervention (PCI) with stents for multivessel coronary artery disease (CAD).

Study Details:

The FAME 3 trial initially aimed to …